Full Answer
The whistleblower, Brook Jackson, was the regional director for the Ventavia Research Group, the company that was conducting Pfizer’s pivotal phase III trial in Texas in 2020. In September of 2020, Jackson emailed a complaint to the FDA, informing the agency of the company’s allegedly dangerous and shoddy research practices.
Brook Jackson whistleblower lawsuit allegations against Ventavia Pfizer and Icon, Defendants admit fraud by filing that fraud is not material to the contract From the Defender.
In an interview with The Defender, the lawyer representing whistleblower Brook Jackson said Pfizer is arguing the court should dismiss Jackson’s lawsuit alleging fraud in Pfizer’s COVID-19 clinical trials because the U.S. government knew about the wrongdoings but continued to do business with the vaccine maker.
In an interview with The Defender, Jackson’s lawyer said Pfizer argued the lawsuit, which was filed under the False Claims Act, should be dismissed because the U.S. government knew of the wrongdoings in the clinical trials but continued to do business with the vaccine maker.
Pfizer paid a total of $1.8 billion to resolve the civil and criminal charges that resulted from Mr. Kopchinski’s whistleblower lawsuit brought under the False Claims Act, which provides whistleblowers with protection against job retaliation and rewards.
Phillips & Cohen is the most successful law firm representing whistleblowers, with recoveries from our cases totaling over $12.3 billion. Our work has been recognized with numerous awards and the praise of our whistleblower clients. Blowing the whistle can be a difficult decision. With more than 30 years of experience with whistleblower cases, Phillips & Cohen can help prepare you before you blow the whistle so that you know what to expect after your case is filed. We are there for our clients. Contact us for a free, confidential consultation.
The Pfizer settlement was the largest healthcare fraud settlement at that time and currently is the second largest. (The biggest healthcare fraud settlement to date, $3 billion, was paid by GlaxoSmithKline, the bulk of which was paid to settle charges related to a qui tam case against Glaxo brought by two whistleblowers who also were represented by ...
Taking on corporate giants can feel like tilting at windmills, but John Kopchinski’s six-year legal battle against Pfizer Inc just made him a rich man.
Phillips & Cohen LLP represented John Kopchinski in a qui tam lawsuit against Pfizer Inc. that alleged the company was engaged in the off-label marketing of Bextra, a painkiller, in dangerous doses and for unapproved, unsafe uses.
Blowing the whistle can be a difficult decision. With more than 30 years of experience with whistleblower cases, Phillips & Cohen can help prepare you before you blow the whist le so that you know what to expect after your case is filed .